A conceivable concept for the development of duodenal ulcers in Helicobacter pylori (H. pylori) infected subjects is presented in this chapter. The concept includes an explanation of the fact that only a minority of all H. pylori-infected subjects will develop a duodenal ulcer. Helicobacter pylori infection of the antrum induces a hypersecretion of gastric acid secretion, giving rise to gastric metaplasia in the duodenal bulb. This gastric metaplasia is a prerequisite for H. pylori colonization of the bulb. These events are common to all H. pylori-infected subjects. However, a much higher density of H. pylori bacteria and colonization with virulent organisms has been found in the bulb of duodenal ulcer patients, resulting in a much stronger in¯ammatory reaction with active duodenitis and an impaired bicarbonate secretion. These characteristics, together with acid hypersecretion, seem to be the important factors in evoking a duodenal ulcer.
There are undoubtedly multiple pathogenic mechanisms involved in the development of duodenal ulcer (DU) disease. Hypersecretion of gastric acid is, however, a common denominator. In fact, massive acid hypersecretion can by itself provoke duodenal ulceration, as exempli®ed by Zollinger±Ellison syndrome. Gastric acid hypersecretion is in all probability a prerequisite in Helicobacter pylori (H. pylori) induced DU, while the level of acid secretion in the relatively few patients with a non-steroidal anti-in¯ammatory drug-induced DU is more uncertain. In all three examples, potent anti-secretory treatment can heal the DU disease and prevent its recurrence.
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The gastric acid secretion in DU patients is characterized by several well-established abnormalities ( Figure 1 ). An increased maximal acid secretory capacity has been unequivocally found in about half of all DU patients. The increased maximal acid output is at least partly dependent on an increased parietal cell mass. 1 The maximal acid response to pentagastrin, which is the most commonly used instrument to determine the maximal acid secretory capacity, might also depend on the number of enterochromane-like cells and the amount of histamine released from these cells in the vicinity of the parietal cells during pentagastrin stimulation. Furthermore, three physiological inhibitory mechanisms have been found to be defective in DU patients: the inhibition of gastrin release by antral acidi®cation 2 , re¯ex inhibition by antral distension 3 , and inhibition by duodenal fat administration (the enterogastron mechanism). 4 One defective inhibitory mechanism has been found in each group of DU patients so far studied, and it is reasonable to assume ± although this has not been studied ± that all three are present in every DU patient. The result of these abnormalities is gastric hypersecretion as an increased and/or prolonged gastric acid response to every meal in DU patients. 5 The most common cause of DU disease is H. pylori infection, and successful eradication of the infection will cure the disease. Only a small percentage ± about 10±15% ± of all those infected will, however, develop a DU. There seems to be a distinct series of events, starting with an antral H. pylori infection, that are necessary to result in a DU. The main actors in this series of events are acid hypersecretion, the development of a large area of gastric metaplasia in the duodenal bulb with colonization of H. pylori in the bulb, a high density of virulent H. pylori bacteria in the bulb with a substantial active and chronic in¯ammatory response, and a marked H. pylori-dependent reduction of bicarbonate secretion in response to acidi®cation of the bulb. The overview will shortly present the evidence for this concept.
HELICOBACTER PYLORI EFFECTS ON GASTRIC ACID SECRETION
In DU patients, the chronic H. pylori infection is predominantly located in the antrum. A pronounced H. pylori infection of the antrum with an intact parietal cell region will result in acid hypersecretion as a result of a blockade of mechanisms normally inhibiting acid secretion. It should be emphasized that this hypersecretion of acid exists in all subjects with an antrum-predominant H. pylori infection and is thus not a characteristic of DU patients. The H. pylori-induced blockade of inhibitory mechanisms leads to a facilitated release of gastrin 6 but involves also the abolishment of inhibitory re¯ex pathways from the antrum to the parietal cell region. 7 However, if the chronic H. pylori infection is also pronounced in the parietal cell region, acid secretion will diminish, partly because of a local inhibitory in¯uence of the H. pylori infection at the parietal cell level and partly because of a decreased parietal cell mass in the case of atrophic gastritis. 8 
Maximal acid secretory capacity
It is well established that DU patients have a signi®cantly higher maximal acid output in response to histamine and pentagastrin than non-DU subjects, but with a substantial overlap. It has been suggested that the unequivocally increased maximal acid secretory capacity that is to be found in about half of the DU patients might be the result of a genetically determined large parietal cell mass.
It has, however, been shown that half a year after H. pylori eradication, the maximal acid response to pentagastrin is signi®cantly reduced in DU patients 9 , although this is not a consistent ®nding. 10 Since gastrin release is facilitated by antral H. pylori infection, a trophic eect of gastrin on the parietal cell region is conceivable. The H. pyloriinduced increases of basal and meal-stimulated serum gastrin levels are of a moderate magnitude. Similar moderately increased serum gastrin levels are produced by treatment with proton pump inhibitors. Eight weeks of treatment of H. pylori-negative subjects with a high dose of omeprazole resulted in a signi®cantly increased maximal acid response to gastrin determined 15 days after the cessation of the omeprazole treatment. 11 The result was ascribed to a trophic eect of the moderately increased serum gastrin levels on the parietal cells. Such an interpretation is in agreement with the reduced maximal acid response to pentagastrin after H. pylori eradication in the study of Harris et al 9 , as well as with the substantial reduction in the maximal acid response to pentagastrin in DU patients after exact antrectomy leaving the whole parietal cell area intact. 12 It has also been shown that the eradication of H. pylori infection signi®cantly reduces the capacity of pentagastrin to mobilize histamine in the parietal cell region mucosa of DU patients. 13 The result implies that H. pylori infection increases the mobilization of histamine from the enterochromane-like cells in the parietal cell region of DU patients, which can contribute to a high maximal acid response to pentagastrin in DU patients.
Why is there such a substantial overlap of the maximal acid outputs in DU patients and non-DU subjects? First, all H. pylori-infected subjects, including non-DU subjects, have a facilitated release of gastrin. Second, there is evidence to suggest that glycineextended gastrins ± another product of progastrin than the traditional amidated gastrins ± have marked trophic eects but low acid-secretory stimulating activity.
14 Glycine-extended gastrins are released simultaneously with the amidated gastrins from the gastrin-producing G-cells in the antrum, but the two gastrin forms act via dierent receptors. It is therefore possible that trophic eects and acid-stimulatory eects may dier between subjects depending on the proportion of the two gastrin forms released from the G-cells.
Defective inhibitory mechanisms
A facilitated gastrin release is well established in H. pylori-infected subjects, both in the fasting state and in response to meals 6,15±17 , as well as after stimulation with gastrinreleasing peptide (GRP). 18, 19 The increased release of gastrin was reduced to normal levels after H. pylori eradication. The facilitated gastrin release in H. pylori-infected subjects is associated with and probably caused by a suppressed action of somatostatin from the antral D-cells. 20, 21 GRP has been used as an experimental instrument to study the eects of H. pylori infection on gastrin release and subsequent acid secretion. However, an intravenous infusion of GRP does not necessarily re¯ect the physiological eects of GRP as a neurotransmitter. Furthermore, GRP releases, apart from gastrin and despite its name, several peptides with an inhibitory eect on acid secretion, for example somatostatin. As expected, GRP-stimulated gastrin and acid secretion are signi®cantly increased in all H. pylori-infected subjects, with a normalization after H. pylori eradication. 10 The increased acid response to GRP in the H. pylori-infected subjects was attributed to a defective inhibition of gastrin release and acid secretion by the suppressed somatostatin function. Most interestingly, the acid response to GRP in H. pylori-infected DU patients was about twice that in H. pylori-infected non-DU subjects, with a minimal overlap despite similar enhancements of serum gastrin level in response to GRP.
10 A reasonable interpretation is that H. pylori-infected non-DU subjects have an increased acid response to GRP as a result of defective inhibitory mechanisms, and that H. pylori-infected DU patients have a further increased acid response to GRP due to a reinforced suppression of inhibitory mechanisms. Consequently, H. pylori-infected DU patients may have ± although this has not been shown ± a higher magnitude of acid hypersecretion than H. pylori-infected non-DU subjects also under physiological conditions. Gastric acid secretion is also increased in all H. pylori-infected subjects by a defective inhibitory mechanism that is unrelated to endogenous gastrin. Antral distension in healthy subjects without H. pylori infection inhibits the gastric acid secretion induced by maximal pentagastrin stimulation. This inhibitory eect is absent in H. pylori-infected subjects but appears after eradication of the H. pylori infection. 7 Since the stimulus for acid secretion was a high dose of pentagastrin, the eect of antral distension is obviously independent of any moderate changes in the release of endogenous gastrin. In fact, and unexpectedly, antral distension in DU patients during concomitant intragastric neutralization in order to optimize the release of gastrin did not result in any increase of serum gastrin level. 22 The inhibitory eect of antral distension on acid secretion in healthy subjects without H. pylori infection is in all probability caused by an inhibitory re¯ex pathway from the antrum to the parietal cell region. The H. pylori infection blocks this inhibitory re¯ex, resulting in a suppressed inhibition of acid secretion. The transmittor mechanisms aected by the impaired re¯ex inhibition from the H. pylori-infected antrum are unknown, but the ®nal link in the re¯ex chain may be located at the enterochromane-like and/or parietal cell level.
Defective inhibitory mechanisms caused by antral H. pylori infection, including a facilitated release of gastrin and a blockade of the inhibitory re¯ex pathways, should be operating under physiological conditions, i.e. during and after meals. An increased release of gastrin during meals in H. pylori-infected subjects is well established.
6,15±17
The gastric acid response to a peptone meal of pH 7.0 was shown to be about twice as high and prolonged in H. pylori-infected subjects compared with non-infected healthy subjects. 17 The hypersecretory acid response to the meal was normalized after eradication of the H. pylori infection. An increased release of gastrin in H. pyloriinfected subjects has also been shown during meals with an acidi®ed antrum. 16, 17 After an acidi®ed meal of pH 2.0, there was a signi®cantly higher gastrin release and acid response in H. pylori-infected subjects compared with non-infected subjects, again with a normalization of both parameters after H. pylori eradication. 17 The well-known mechanism by which acidi®cation of the antrum inhibits gastrin release and the gastric acid response to gastrin is thus clearly impaired in H. pylori-infected subjects. The increased gastric acid responses to neutral and acidi®ed meals in H. pylori-infected subjects could not, however, be explained entirely by the increased release of gastrin.
17 It is therefore reasonable to assume that other defective inhibitory mechanisms, for example the impaired inhibitory distension re¯ex from the antrum to the parietal cell region 7 , must contribute. The inhibitory enterogastrone mechanism is defective in DU patients 3 , but whether this inhibitory mechanism is also blocked by H. pylori infection has not been ascertained.
In summary, antral H. pylori infection causes gastric acid hypersecretion by a blockade of physiological inhibitory mechanisms, resulting in an increased and prolonged acid response to meals. At least in the experimental situation of intravenous GRP stimulation, the acid hypersecretion is accelerated in DU patients. The ®nal result is an increased duodenal acid load in subjects with an antral H. pylori infection.
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GASTRIC METAPLASIA
Gastric metaplasia (GM) of the duodenal bulb is a prerequisite for H. pylori colonization of the bulb. GM develops in response to an increased duodenal acid load, and extensive gastric metaplasia has been found in the duodenum of patients with Zollinger±Ellison syndrome. 23 GM has been found at a high frequency in H. pyloriinfected subjects, with a prevalence of about 90% in DU patients and about 60% in non-DU subjects 24±26 , both groups having an increased duodenal acid load. It has, however, been proposed that a severe in¯ammation of the GM islands caused by H. pylori may further increase the extent of GM primarily induced by acid hypersecretion. 27 The concept that the extent of GM is partly dependent on the H. pylori-activated in¯am-matory process in the GM has been supported by the ®nding that the combination of H. pylori eradication and acid suppression produced a greater reduction in GM than either treatment alone. 28 Antral H. pylori infection results in a hypersecretion of acid and a high prevalence of GM in both DU patients and non-DU subjects, albeit with some preponderence in DU patients. It therefore seems reasonable to assume that a critical factor in the development of DU may be a high number of H. pylori bacteria and/or particularly virulent strains of H. pylori in the duodenal bulb. The aim of a recent study was systematically to determine the extent of GM, the quantity and the cytotoxin-associated gene A (cagA) status of H. pylori, and the severity of in¯ammation in biopsies from both the antrum and the duodenal bulb in DU patients and asymptomatic infected subjects. 26 Such comparisons of H. pylori status and degree of in¯ammation between the antrum and duodenal bulb in the same subject, and between DU patients and non-DU subjects, have not previously been undertaken. The extent of GM had to be carefully determined to make a meaningful comparison of the other parameters between the DU and non-DU subjects. Since GM is patchy and as yet cannot be visualized during endoscopy, a high number of biopsies had to be taken from the duodenal bulb: two from each quadrant. The extent of GM was almost four-fold greater in the H. pyloriinfected DU patients compared with the H. pylori-infected non-DU subjects. 26 
BACTERIAL DENSITY AND CAGA STATUS IN THE DUODENAL BULB
A very high prevalence of H. pylori has been found in the duodenal bulb of both DU patients (95%) and infected non-DU subjects (80%) 26 , suggesting that colonization of GM in the bulb is a common phenomenon. Rigorous precautions were taken to avoid contamination of the duodenal biopsies by H. pylori from the stomach during endoscopy. Therefore, the high prevalence ®gures of H. pylori in the duodenal bulb in all probability represent a true colonization of the bulb and were the results of the sensitive technique of quantitative culture. 29 It seems, however, that a certain H. pylori density in the antrum ± about 10 4 colony-forming units in a biopsy ± is required for colonization of the bulb to occur. 26 Lewis antigens on H. pylori lipopolysaccharides may contribute to permanent colonization by facilitating the attachment of H. pylori to gastric or metaplastic epithelium 30 , and by allowing H. pylori to escape from host responses. H. pylori strains from the duodenal bulb expressed Lewis antigens in 90% of DU patients and only 42% of non-DU subjects. 31 The H. pylori density in the duodenal bulb was much lower than in the antrum, even after correction for the area of GM 26 , suggesting that the duodenum constitutes a less favourable environment for colonization with H. pylori. However, the mean density of H. pylori in the duodenal bulb was 20 times higher in DU than in non-DU subjects 26 despite the fact that the H. pylori density in the antrum was the same in the two groups, yet there was a considerable overlap in the duodenal H. pylori density between DU patients and non-DU subjects. It has been shown that cagA positivity is related to the density of H. pylori in the antrum. 29, 32 Similarly, it was found that subjects with cagA strains in the duodenal bulb had a 10-fold higher H. pylori density in the bulb than did subjects with cagA strains. 26 An association between H. pylori-induced DU and cagA positivity has frequently been observed, but in several reports there has been no signi®cant dierence in the prevalence of cagA strains in the antrum between DU patients and non-DU subjects. It appears that cagA positivity is a marker for a more virulent group of H. pylori strains possessing a cluster of additional genes encoded by a pathogenicity island. 32, 33 Some of these additional genes in cagA strains induce pro-in¯ammatory cytokines with mucosadamaging potential. 34 It should be emphasized that multiple strains, including cagA and cagA strains, can exist in the same subject. 26, 35, 36 Since, at least in the duodenal bulb, colonies from each biopsy always showed the same cagA status 26 , it is necessary to culture from multiple biopsies to determine the predominant strain. Therefore the proportion of cagA-positive bacteria in relation to the total number of organisms may be an important factor determining the local damaging potential of H. pylori colonization.
A new and signi®cant ®nding was the fact that DU patients had a much higher prevalence of cagA H. pylori strains in the duodenal bulb (81%) than did H. pyloriinfected non-DU subjects (30%), despite a marginal dierence in the prevalence of cagA strains in the antrum of the same subjects (86% versus 75%). 26 Consequently, the GM environment in the duodenal bulb seems to constitute a separate entity disengaged from the conditions in the gastric antrum for permanent H. pylori colonization.
HELICOBACTER PYLORI-INDUCED INFLAMMATION IN THE DUODENAL BULB
The in¯ammatory cells are found in association with areas of GM. Chronic duodenitis, determined by scoring the lymphocytic in®ltration, was more marked in H. pyloriinfected DU patients than in H. pylori-infected non-DU subjects but again with a considerable overlap. 26 Positive mutual relations were found between the extent of GM, the bacterial density and the chronic in¯ammatory score.
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Active duodenitis, de®ned by the presence of neutrophils, is a common ®nding in DU patients. In a recent study of H. pylori-infected DU patients and non-DU subjects, active duodenitis was found only in DU patients and almost exclusively in DU patients with cagA strains in the duodenal bulb. 26 CagA strains induce much higher levels of the pro-in¯ammatory cytokine interleukin 8 (IL-8) in gastric epithelial cells in vitro than do cagAÀ strains. 34, 37 CagA strains have also induced an increased in¯ammation in the gastric mucosa in vivo, at least partly because of the activation of IL-8. 38 Close contact between the H. pylori and gastric epithelial cells seems to be necessary for inducing a substantial IL-8 response 34,37 since culture supernatant and non-living H. pylori did not produce any signi®cant response. However, disruption of the cagA gene did not reduce the IL-8 activation in gastric epithelial cells. 39 Instead, the picB gene, located in the vicinity of the cagA gene, seems to be needed for IL-8 induction. 40 The picB gene is invariably linked with cagA, and the cagA±picB gene cluster constitutes a large pathogenicity island unique to cagA strains and responsible for IL-8 induction.
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CagA is thus a marker for virulence, but its own function is unknown. The combination of cagA strains, the picB gene and IL-8 production, together with a high duodenal acid load, forms a conceivable trigger mechanism for tissue damage and ulcer formation in the duodenal bulb. IL-8 provokes the accumulation and activation of neutrophils capable of releasing proteolytic enzymes with tissue-damaging potential 41 , as well as inducing reactive oxygen metabolites in gastric epithelial cells 42 , with an additional tissue-damaging eect.
BICARBONATE SECRETION IN THE DUODENAL BULB
A high duodenal acid load has the potential to damage the mucosa in the duodenal bulb. The ®rst line of defence against luminal acidity is increased duodenal bicarbonate secretion in response to the acidi®cation. The bicarbonate will neutralize the acid, forming carbon dioxide and water. It is now established that the duodenal bicarbonate secretion in response to acidi®cation is a nitric oxide (NO) dependent mechanism. The NO synthase inhibitor L-NAME, administered into the duodenal perfusate of rats, blocked the bicarbonate response to acidi®cation. 43 Furthermore, acidi®cation of the proximal duodenum of pigs resulted in a simultaneous increase of bicarbonate secretion and NO production that was determined directly by chemiluminescence. 44 Both responses were inhibited by the intraluminal administration of the NO synthase inhibitor L-NMMA, the inhibitory eect of which could be reversed by the administration of the normal substrate L-arginine. Carbon dioxide seems to be the mediator of the duodenal bicarbonate response to acidi®cation since a high carbon dioxide tension in a neutral duodenal perfusate stimulated the bicarbonate secretion, and this response could be blocked by a NO synthase inhibitor. 45 The presence of inducible NO synthase immunoreactivity has recently been demonstrated in the duodenal mucosa, being found to be most prominent at the tips of the villi. 46 Duodenal acidi®cation produced a marked increase of this NO synthase expression. Furthermore, the bicarbonate response to duodenal acidi®cation could be blocked by a selective inhibitor of inducible NO synthase. In summary, it seems that duodenal acidi®cation via carbon dioxide activates inducible NO synthase in the epithelial cells and that the resulting NO stimulates the bicarbonate secretion. DU patients have impaired bicarbonate secretion in response to acidi®cation of the duodenal bulb. 47 The defective bicarbonate response to duodenal acidi®cation in DU patients has been found to be dependent on the presence of H. pylori infection since the bicarbonate response was normalized after H. pylori eradication.
48 It was also shown that the bicarbonate response to duodenal acidi®cation was not signi®cantly impaired in H. pylori-infected non-DU subjects. Consequently, it seems that the impairment of the bicarbonate response to duodenal acidi®cation caused by H. pylori infection is a characteristic of DU patients.
The mechanism by which H. pylori infection interferes with duodenal bicarbonate secretion has been the subject of recent studies. Water extracts of H. pylori bacteria administered to the duodenal perfusate in rats have been shown to abolish the bicarbonate response to acidi®cation. 49 The bicarbonate response in these experiments was normalized after administration of the NO synthase substrate L-arginine to the duodenal perfusate, suggesting that the H. pylori bacteria interfered with the NO synthase activity in the duodenal epithelial cells. Furthermore, the concentration of the endogenous NO synthase inhibitor asymmetric dimethyl arginine (ADMA) was markedly increased in both the duodenal perfusate and the duodenal tissue after exposure to the H. pylori extract. The proteolysis of H. pylori was shown to produce ADMA, and substituting the H. pylori extract for ADMA in the duodenal perfusate also blocked the bicarbonate response to duodenal acidi®cation. The mucosal concentrations of L-arginine and ADMA have been determined in the antrum of H. pyloriinfected and non-infected subjects. L-arginine concentrations were about the same in both groups, while the ADMA concentrations were about 65 times higher in the antral mucosa of H. pylori-infected subjects. 50 It would be most interesting to study whether the same is true for the duodenal mucosa, and whether cagA strains of H. pylori are particularly eective in producing ADMA. It seems reasonable to assume that H. pylori ± dead or alive ± deliver peptides that, in the antrum and duodenal bulb, are degraded by proteolysis to various amino acid residues, including the NO synthase inhibitor ADMA. The presence of H. pylori-induced ADMA could interfere with NO synthase in the duodenal epithelial cells and contribute to an impairment of the bicarbonate response to duodenal acidi®cation. Speculatively, the high density of cagA strains of H. pylori in the duodenal bulb of DU patients might explain the impaired bicarbonate response to duodenal acidi®cation that is a characteristic of DU patients.
WHY DOES DUODENAL ULCER DEVELOP IN ONLY A MINORITY OF HELICOBACTER PYLORI-INFECTED SUBJECTS?
Although there is no de®nite answer to this question at present, evidence is accumulating to show a conceivable chain of events leading to a DU in a H. pylori-infected subject. The H. pylori infection in the antrum creates the necessary conditions by inducing gastric acid hypersecretion as a result of an interference with mechanisms normally inhibiting gastrin release and acid secretion. The resulting increased duodenal acid load gives rise to islands of gastric metaplasia in the duodenal bulb, which then can be colonized by H. pylori. The sequence of events is, however, common to all H. pyloriinfected subjects (Figure 2) .
A critical factor in the development of a duodenal ulcer seems to be the quantity of virulent H. pylori strains in the duodenal bulb. When the quantity of virulent bacteria is high enough, another series of events is provoked, leading to a DU. In fact, DU patients have a much higher density of virulent H. pylori bacteria in the duodenal bulb ± with cagA positivity as a marker for virulence ± than do H. pylori-infected subjects without a DU. This higher density of virulent organisms in the bulb gives rise to two eects characteristic for DU patients. First, the comparatively large number of virulent bacteria induces a substantial release of particularly pro-in¯ammatory cytokines, resulting in a much stronger in¯ammatory reaction than in infected non-DU subjects, with a higher degree of chronic in¯ammation and an active duodenitis with neutrophil in®ltration, the latter being unique for DU patients. The neutrophil in®ltration may cause a further increase of the gastric metaplastic area in the bulb and entails a marked potential for tissue damage. Second, it seems probable that the high density of virulent H. pylori bacteria in the bulb of DU patients produces a suciently high concentration of the NO synthase inhibitor ADMA to substantially impair the NO dependent bicarbonate response to duodenal acidi®cation. This means a higher degree of acidity in the bulb of DU patients, in turn leading to a larger area of GM and to an increased potential for tissue damage. In summary, a conceivable concept for development of a DU in H. pylori-infected subjects involves the hypersecretion of gastric acid and a sucient number of virulent strains colonizing the duodenal bulb, followed by an active duodenitis and impaired bicarbonate secretion in the bulb (Figure 3 ).
